| index | Title |
| 1 | Adenovirus-mediated wild-type p53 gene transfer in combination with bronchial arterial infusion for treatment of advanced non-small-cell lung cancer, one year follow-up Author(s):Yong-song GUAN, Yuan LIU, Qing ZOU, Qing HE, Zi LA, Lin YANG, Ying HU Clicked:11152 Download:5658 Cited:14 <Full Text> Journal of Zhejiang University Science B 2009 Vol.10 No.5 P.331-340 DOI:10.1631/jzus.B0820248 |
| 2 | Pharmacokinetics of gemcitabine in Chinese patients with non-small-cell lung cancer Author(s):WANG Lin-run, HUANG Ming-zhu, XU Nong, SHENTU Jian-zhong, LIU Jian, CAI Jie Clicked:10034 Download:5030 Cited:13 <Full Text> Journal of Zhejiang University Science B 2005 Vol.6 No.5 P.446-450 DOI:10.1631/jzus.2005.B0446 |
| 3 | RRM1 gene expression in peripheral blood is predictive of shorter survival in Chinese patients with advanced non-small-cell lung cancer treated by gemcitabine and platinum Author(s):Lin-run Wang, Guo-bing Zhang, Jian Chen, Jun Li, Ming-wei Li, Nong Xu, Yang Wang, Jian-zhong Shentu Clicked:10650 Download:5008 Cited:9 <Full Text> Journal of Zhejiang University Science B 2011 Vol.12 No.3 P.174-179 DOI:10.1631/jzus.B1000197 |
| 4 | XRCC1 Arg399Gln and clinical outcome of platinum-based treatment for advanced non-small cell lung cancer: a meta-analysis in 17 studies Author(s):Jian Chen, Qing-wei Zhao, Gen-ming Shi, Lin-run Wang Clicked:10891 Download:5710 Cited:17 <Full Text> Journal of Zhejiang University Science B 2012 Vol.13 No.11 P.875-883 DOI:10.1631/jzus.B1200083 |
| 5 | Methylenetetrahydrofolate reductase C677T polymorphism predicts response and time to progression to gemcitabine-based chemotherapy for advanced non-small cell lung cancer in a Chinese Han population Author(s):Wei Hong, Kai Wang, Yi-ping Zhang, Jun-yan Kou, Dan Hong, Dan Su, Wei-min Mao, Xin-min Yu, Fa-jun Xie, Xiao-jian Wang Clicked:9991 Download:5599 Cited:16 <Full Text> Journal of Zhejiang University Science B 2013 Vol.14 No.3 P.207-215 DOI:10.1631/jzus.B1200101 |
| 6 | Down-regulation of eIF5A-2 prevents epithelial-mesenchymal transition in non-small-cell lung cancer cells Author(s):Guo-dong Xu, Xin-bao Shi, Le-bo Sun, Qing-yun Zhou, Da-wei Zheng, Huo-shun Shi, Yong-liang Che, Zi-shan Wang, Guo-feng Shao Clicked:10687 Download:5936 Cited:2 <Full Text> Journal of Zhejiang University Science B 2013 Vol.14 No.6 P.460-467 DOI:10.1631/jzus.B1200200 |
| 7 | Role of LINC00152 in non-small cell lung cancer Author(s):Hong Yu, Shu-Bin Li Clicked:6506 Download:3945 Cited:0 <Full Text> Journal of Zhejiang University Science B 2020 Vol.21 No.3 P.179-191 DOI:10.1631/jzus.B1900312 |
| 8 | Optimized thyroid transcription factor-1 core promoter-driven microRNA-7 expression effectively inhibits the growth of human non-small-cell lung cancer cells Author(s):Shipeng CHEN, Lian GUAN, Xu ZHAO, Jing YANG, Longqing CHEN, Mengmeng GUO, Juanjuan ZHAO, Chao CHEN, Ya ZHOU, Yong HAN, Lin XU Clicked:4838 Download:3650 Cited:0 <Full Text> <PPT> 1632 Journal of Zhejiang University Science B 2022 Vol.23 No.11 P.915-930 DOI:10.1631/jzus.B2200116 |
| 9 | Development and validation of a risk-prediction model for immune-related adverse events in patients with non-small-cell lung cancer receiving PD-1/PD-L1 inhibitors Author(s):Qing QIU, Chenghao WU, Wenxiao TANG, Longfei JI, Guangwei DAI, Yuzhen GAO, Enguo CHEN, Hanliang JIANG, Xinyou XIE, Jun ZHANG Clicked:4208 Download:3237 Cited:0 <Full Text> <PPT> 1328 Journal of Zhejiang University Science B 2023 Vol.24 No.10 P.935-942 DOI:10.1631/jzus.B2200631 |
| 10 | Depleting CBR1 increases chemosensitivity by reducing stemness and quiescence traits in non-small cell lung cancer Author(s):Weiwen LI, Jialu ZHAO, Weihong LAN, Xiaofei YE, Kejing YING Clicked:3280 Download:3673 Cited:0 <Full Text> <PPT> 608 Journal of Zhejiang University Science B 2025 Vol.26 No.12 P.1216-1232 DOI:10.1631/jzus.B2400509 |
